Skip to main content
Clinical Trials/CTRI/2022/03/041353
CTRI/2022/03/041353
Not yet recruiting
未知

To compare the neurodevelopmental outcomes of neonates with asymptomatic moderate to severe hypoglycemia vs symptomatic hypoglycemia

none0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: E15-E16- Other disorders of glucose regulation and pancreatic internal secretion
Sponsor
none
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • DetailsNeonates of gestation \> 32 weeks with hypoglycemia (both symptomatic and asymptomatic) on hand held glucometer reading will be considered

Exclusion Criteria

  • 1\)Infants with major congenital malformations
  • 2\)Infants with persistent hypoglycemia secondary to panhypopituitarism or other endocrine causes
  • 3\)Infants with inborn errors of metabolism
  • 4\)Perinatal asphyxia
  • 5\)Parents who are unwilling to give consent for follow up visit at 6\-9 months of life

Outcomes

Primary Outcomes

Not specified

Similar Trials